US EditionSynerFuse™ & Velentium Medical Partnering to Scale Integrated Spinal Fusion & Direct Nerve Stimulation Procedure
- SynerFuse and Velentium Medical announced plans to scale their patented SynerFuse e-TLIF procedure implant device following the completion of their proof-of-concept study.
- Spinal fusion procedures can lead to complications like Failed Back Surgery Syndrome, which affects many patients and costs the U.S. healthcare system $20 billion per year.
- The SynerFuse e-TLIF procedure aims to improve patient safety with a single incision and integrates neuromodulation with traditional spinal fusion techniques.
- Doctors believe this new therapy offers a safe option for treating back and leg pain while reducing opioid exposure for patients.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
Coverage Details
Total News Sources14
Leaning Left0Leaning Right0Center5Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium